{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:10:34Z","timestamp":1793729434696,"version":"4.6.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.clgc.2025.102357","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T18:12:38Z","timestamp":1744654358000},"page":"102357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of the Impact of Grade Heterogeneity on Survival in Ta and T1 Tumors: A Subgroup Analysis of NMIBC Cohort"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6917-9051","authenticated-orcid":false,"given":"Murat Can","family":"Karaburun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2739-6124","authenticated-orcid":false,"given":"Ezgi Dicle","family":"Serbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7a\u011fr\u0131","family":"Akp\u0131nar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Obaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagatay","family":"G\u00f6\u011f\u00fc\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Kiremitci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duygu","family":"Enneli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7604-841X","authenticated-orcid":false,"given":"S\u00fcmer","family":"Baltac\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evren","family":"S\u00fcer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2025.102357_bib0001","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102357_bib0002","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","article-title":"Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model","volume":"182","author":"Fernandez-Gomez","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2025.102357_bib0003","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.eururo.2024.02.009","article-title":"International Society of Urological Pathology Consensus Conference on current issues in bladder cancer: main conclusions and recommendations","volume":"85","author":"van der Kwast","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102357_bib0004","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/JU.0000000000003990","article-title":"Grade heterogeneity in high-Grade urothelial carcinomas: does it have an impact on the survival of patients with intermediate\/high-risk nonmuscle-invasive bladder cancer who received adequate adjuvant Bacillus Calmette-Gu\u00e9rin therapy?","volume":"212","author":"Karaburun","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2025.102357_bib0005","first-page":"2016","article-title":"Definitions, end points, and clinical trial designs for non\u2013muscle-invasive bladder cancer: recommendations from the International Bladder Cancer Group","volume":"34","author":"Kamat","year":"1935","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2025.102357_bib0006","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clgc.2025.102357_bib0007","series-title":"Cancer IAfRo: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs","author":"Eble","year":"2004"},{"key":"10.1016\/j.clgc.2025.102357_bib0008","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/his.14764","article-title":"What's new in WHO fifth edition\u2009-\u2009urinary tract","volume":"81","author":"Comp\u00e9rat","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.clgc.2025.102357_bib0009","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.juro.2013.11.056","article-title":"Mixed high and low grade bladder tumors\u2013are they clinically high or low grade?","volume":"191","author":"Gofrit","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2025.102357_bib0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/003655901750425837","article-title":"Tumor grade heterogeneity in urothelial bladder carcinoma\u2013proposal of a system using combined numbers","volume":"35","author":"Billis","year":"2001","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.clgc.2025.102357_bib0011","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.humpath.2015.09.007","article-title":"Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder","volume":"47","author":"Reis","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.clgc.2025.102357_bib0012","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00428-023-03625-3","article-title":"Clinicopathologic features and prognostic significance of mixed (Low and high-grade) papillary urothelial carcinoma comparison with low and high-grade papillary urothelial carcinoma","volume":"483","author":"Kir","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.clgc.2025.102357_bib0013","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.urology.2024.06.035","article-title":"Does Ta low-grade urothelial carcinoma of the bladder with focal high-grade features carry worse prognosis? The Roswell Park Comprehensive Cancer Center experience","volume":"193","author":"Abou Heidar","year":"2024","journal-title":"Urology"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:52:36Z","timestamp":1752609156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325000588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1558767325000588"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102357","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of the Impact of Grade Heterogeneity on Survival in Ta and T1 Tumors: A Subgroup Analysis of NMIBC Cohort","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102357"}}